Intravenous Laser Blood Irradiation in the Management of Juvenile Idiopathic Arthritis

摘要

The aim of the study was to evaluate the response to Intravenous Laser Blood Irradiation Therapy (ILBIT) in patients with moderate and severe Juvenile Idiopathic Arthritis (JIA). 20 patients (Group 1) with JIA received ILBIT with a GaAlAs probe (3 mW, cw, 630 nm), 15 minutes each session, 10 consecutive days, concomitantly with conventional therapy, comparatively with 16 JIA patients (Group 2 - control), who received remissive therapy and placebo laser therapy. Patients' outcome was measured with the Simplified Disease Activity Index criteria. In Group 1, ILBIT reduced the number of tender / swollen joins, offered the patient a better personal experience regarding pain and its control, with statistically significant difference, compared to control group.